Previous Close | 1.8600 |
Open | 1.8320 |
Bid | 1.7400 x 14100 |
Ask | 1.7600 x 300 |
Day's Range | 1.7500 - 1.8500 |
52 Week Range | 1.5000 - 3.4000 |
Volume | |
Avg. Volume | 17,671,909 |
Market Cap | 1.475B |
Beta (5Y Monthly) | 2.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3300 |
Earnings Date | Oct 02, 2024 - Oct 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.39 |
Drug Enforcement Administration (DEA) officials has set the date for a hearing to possibly reclassify marijuana to a Schedule 1 drug on December 2, after the 2024 presidential election. Cannabis stocks, including Curaleaf (CURLF), Tilray (TLRY), Green Thumb (GTBIF), Cresco Labs (CRLBF), and Verano Holdings (VRNOF), are sliding on this news. For more expert insight and the latest market action, click?here?to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
Its strategic ambitions for its beer business are quickly becoming a reality.
Concert Proceeds to Support Project C.U.R.E.LITTLETON, Colo., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery (“Breck Brew”), a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is excited to announce the next On Tap concert series in partnership with 97.3 KBCO (iHeartMedia-Denver) and live music by Kaleo, along with Hippo Campus and Cassandra Lewis. The On Tap concert taking place on Saturday, October 12, 2024, will be an unforgettable night at Breckenridge Brewery’s scenic